Article
Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acids.
Journal of clinical microbiology - 1 Dec 2010
Hige Shuhei, Yamamoto Yoichi, Yoshida Shigeru, Kobayashi Tomoe, Horimoto Hiromasa, Yamamoto Keiko, Sho Takuya, Natsuizaka Mitsuteru, Nakanishi Mitsuru, Chuma Makoto, Asaka Masahiro
Abstract excerpt
Lamivudine is the first nucleoside analogue that was shown to have a potent effect on hepatitis B virus (HBV). However, the emergence of mutants resistant or cross-resistant to nucleoside/nucleotide analogues remains a serious problem. Several assays for the detection and quantification of antiviral-resistant mutants have been reported, but it has been difficult to measure the amounts of mutants accurately,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
